Bern Paul uses close to 10 products from different manufacturers to manage his urostomy after bladder cancer. He explains why Medicare bidding concerns him.
News|Articles|February 24, 2026
Experts Preview Practice-Changing Data Ahead of 2026 ASCO GU
Author(s)Ryan Scott
Fact checked by: Alex Biese
Oncologists highlight key 2026 ASCO GU studies in bladder, prostate, kidney and testicular cancers that could reshape treatment and personalize care.
Advertisement
Advertisement
As the cancer community gets ready for the 2026 ASCO Genitourinary (GU) Cancers Symposium, we at CURE are focusing on what the latest research could mean for people living with bladder, prostate, kidney, testicular and other genitourinary cancers. This annual meeting often brings news about new treatments, better ways to use current therapies and ways that may help doctors personalize care.
Related to this article
Five-year results presented at ASTRO 2026 show a five-week radiation schedule after prostatectomy controls cancer as well as a seven-week course. But serious urinary side effects were more common.
A Phase 3 trial of firmonertinib did not meet its main goal in a hard-to-treat lung cancer subtype, though the drug caused fewer serious side effects than chemotherapy.
In a study of more than 250,000 older adults presented at ASTRO 2026, people with depression who started talk therapy within a week of their cancer diagnosis had a 27% lower risk of dying from their cancer. But most people with depression received no mental health treatment at all.
Epkinly plus R-CHOP lowered the risk of disease progression or death by 51% versus R-CHOP alone in patients with newly diagnosed diffuse large B-cell lymphoma.
Living with incurable small lymphocytic lymphoma means facing new health challenges and fears while finding a balance between caution, optimism and daily life.
Breast cancer survivor Sue Weldon discusses survivorship gaps, integrative therapies alongside treatment and why caregivers should prioritize themselves.
Endoscopic nipple-sparing mastectomy may improve recovery, reduce scarring and support quality of life for people undergoing breast cancer surgery.
Advertisement
Advertisement